October 8, 2010
Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. It develops drugs for endometriosis, anxiety, depression, pain, diabetes, irritable bowel syndrome, insomnia, and other neurological and endocrine-related diseases and disorders. The company’s research programs comprise Glucose Dependent Insulin [...]
Read the full article →
March 1, 2010
In an effort to become current on finnacial reporting BioElectronics has updated its financial reporting status. Today it announced the completion of an independent audit which covered a three-year period ending on December 31, 2008 and a period from April 2000 through December 2008. BioElectronics Corp.(BIEL – News), is the maker of inexpensive, disposable drug-free [...]
Read the full article →